RA CAPITAL MANAGEMENT, L.P. — Form SCHEDULE 13D/A
Filed July 7, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 28/100
What the filing says
RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P., and RA Capital Nexus Fund III, L.P. executed a joint filing agreement dated July 7, 2026, to file a single Schedule 13G and/or 13D statement regarding beneficially owned common stock of Climb Bio, Inc. (par value $0.0001/share). The agreement permits termination by any filer with one week's notice. No ownership percentages, share counts, or dollar amounts are disclosed in this procedural document.
Why this rating
Joint filing agreement is administrative coordination; no ownership %, share count, or valuation disclosed; routine SEC procedural filing.
See more from July 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.